Publications by authors named "Michael T Flavin"

Claim this Profile
S
Safety and tolerability of pooled human immune globulins after topical ophthalmic administration in New Zealand White rabbits.
Simon Kaja, Sana Iqbal, Berta Pons Lopez, Sergio Molina Zaragoza, Christine Mun, Michael T Flavin

Cutan Ocul Toxicol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment.
Oleksii Dubrovskyi, Erica Hasten, Steven M Dudek, Michael T Flavin, Leo Li-Ying Chan

SLAS Discov· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structures of human plasma β-factor XIIa cocrystallized with potent inhibitors.
Alexey Dementiev, Abel Silva, Calvin Yee, Zhe Li, Michael T Flavin

Blood Adv· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combating multidrug-resistant Gram-negative bacterial infections.
Ze-Qi Xu, Michael T Flavin, John Flavin

Expert Opin Investig Drugs· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of post exposure administration of doxycycline in a murine model of inhalational melioidosis.
H Carl Gelhaus, Michael S Anderson, David A Fisher, Michael T Flavin, Ze-Qi Xu

Sci Rep· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase I inhibitors and antitumor agents.
David E Zembower, Yongping Xie, Ali Koohang, Mary J Kuffel, Matthew M Ames, Michael T Flavin

Anticancer Agents Med Chem· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies.
Marci L English, Christine E Fredericks, Nancy A Milanesio, Nestor Rohowsky, Ze-Qi Xu, Michael T Flavin

Antimicrob Agents Chemother· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, proapoptotic screening, and structure-activity relationships of novel aza-lupane triterpenoids.
Aye Aye Mar, Erika L Szotek, Ali Koohang, William P Flavin, David A Eiznhamer, Michael T Flavin

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and cytotoxicity of 2-cyano-28-hydroxy-lup-1-en-3-ones.
Ali Koohang, Nathan D Majewski, Erika L Szotek, Aye Aye Mar, David A Eiznhamer, Michael T Flavin

Bioorg Med Chem Lett· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis.
Ze-Qi Xu, Krzysztof Pupek, William J Suling, Livia Enache, Michael T Flavin

Bioorg Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective attenuation of endotoxin-induced acute lung injury by 2,3-diacetyloxybenzoic acid in two independent animal models.
David A Eiznhamer, Michael T Flavin, Gary J Jesmok, Julian F Borgia, Deanna J Nelson

Pulm Pharmacol Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
Ze-Qi Xu, William W Barrow, William J Suling, Louise Westbrook, Esther Barrow, Michael T Flavin

Bioorg Med Chem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers.
David A Eiznhamer, Terri Creagh, Jon L Ruckle, Dwain T Tolbert, Jeremy Giltner, Michael T Flavin

HIV Clin Trials· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chalcones and flavonoids as anti-tuberculosis agents.
Yuh-Meei Lin, Yasheen Zhou, Michael T Flavin, Li-Ming Zhou, Weiguo Nie

Bioorg Med Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replication.
Dale L Barnard, Z e Q i Xu, Valerie D Stowell, Hongwei Yuan, Donald F Smee, Michael T Flavin

Antivir Chem Chemother· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of New Wittig Reagents and Their Application to the Synthesis of alpha,beta-Unsaturated Phosphonates.
Yibo Xu, Michael T. Flavin, Ze-Qi Xu

J Org Chem· November 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis